国际肿瘤学杂志››2014,Vol. 41››Issue (11): 827-829.doi:10.3760/cma.j.issn.1673-422X.2014.11.009
出版日期:
2014-12-03发布日期:
2015-01-20通讯作者:
王小虎, Email: xhwanggs@yahoo.com.cn基金资助:
甘肃省技术开发专项(1004TCYA006)
Online:
2014-12-03Published:
2015-01-20Contact:
Wang Xiaohu,Email: xhwanggs@yahoo.com.cn摘要:内乳淋巴结属于乳腺淋巴引流的第一站淋巴结,在乳腺癌的发生、发展过程中扮演着重要角色。临床上对内乳淋巴结是否行放疗还有很大争议。目前认为,对于早期患者,内乳淋巴结照射的疗效并不明确。而对腋窝淋巴结阳性、内侧象限或中央区病变患者,术后对内乳淋巴结进行放疗具有一定的价值。
吕青芳, 张秋宁, 王小虎. 乳腺癌术后内乳淋巴结的放疗[J]. 国际肿瘤学杂志, 2014, 41(11): 827-829.
吕Qing-Fang , ZHANG Qiu-Ning, WANG Xiao-Hu. Postoperative radiotherapy of internal mammary nodes in breast cancer[J]. Journal of International Oncology, 2014, 41(11): 827-829.
[1] Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast conserving surgery on 10year recurrence and 15year breast cancer death: metaanalysis of individual patient data for 10,801 women in 17 randomised trials[J]. Lancet, 2011, 378(9804):17071716. [2] Sedlmayer F, SautterBihl ML, Budach W, et al. DEGRO practical guidelines: radiotherapy of breast cancer Ⅰ: radiotherapy following breast conserving therapy for invasive breast cancer[J]. Strahlenther Onkol, 2013, 189(10):825833. [3] Carkaci S, Adrada BE, Rohren E, et al. Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?[J]. Acad Radiol, 2012, 19(5):535541. [4] Koo MY, Lee SK, Bae SY, et al. Longterm outcome of internal mammary lymph node detected by lymphoscintigraphy in early breast cancer[J]. J Breast Cancer, 2012, 15(1):98104. [5] Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15year survival: an overview of the randomized trials[J]. Lancet, 2005, 366(9503):20872106. [6] Hooning MJ, Botma A, Aleman BM, et al. Longterm risk of cardiovascular disease in 10year survivors of breast cancer[J]. J Natl Cancer Inst, 2007, 99(5):365375. [7] Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage Ⅰ to Ⅲ breast cancer (EORTC trial 22922/10925)[J]. Acta Oncol, 2010, 49(1):2434. [8] NCCN National Comprehensive Cancer Network. 2014 NCCN Breast Cancer Guidelines(2014.V1). America: NCCN.2014. [9] 殷蔚伯, 余子豪, 徐果镇, 等. 肿瘤放射治疗学[M]. 第四版. 北京: 中国协和医科大学出版社, 2008:11641190. [10] Stemmer SM, Rizel S, Hardan I, et al. The role of irradiation of the internal mammary lymph nodes in highrisk stage Ⅱ to ⅢA breast cancer patients after highdose chemotherapy: a prospective sequential nonrandomized study[J]. J Clin Oncol, 2003, 21(14):27132718. [11] Olson RA, Woods R, Speers C, et al. Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A populationbased analysis in British Columbia[J]. Int J Radiat Oncol Biol Phys, 2012, 83(1):e3541. [12] Chang JS, Park W, Kim YB, et al. Longterm survival outcomes following internal mammary node irradiation in stage ⅡⅢ breast cancer: results of a large retrospective study with 12year followup[J]. Int J Radiat Oncol Biol Phys, 2013, 86(5):867872. [13] Courdi A, Chamorey E, Ferrero JM, et al. Influence of internal mammary node irradiation on longterm outcome and contralateral breast cancer incidence in nodenegative breast cancer patients[J]. Radiother Oncol, 2013, 108(2):259265. [14] Hennequin C, Bossard N, ServagiVernat S, et al. Tenyear survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy[J]. Int J Radiat Oncol Biol Phys, 2013, 86(5):860866. [15] Poortmans PSH, Kirkove C, Budach V, et al. Irradiation of the internal mammary and medial supraclavicular lymph nodes in stage Ⅰ to Ⅲ breast cancer: 10 year results of the EORTC radiation oncology and breast cancer groups phase Ⅲ trial 22922/10925[C]. EJC, 2013, 49Suppl 3:abstr BA2. [16] Whelan TJ, Olivotto I, Ackerman I, et al. NCICCTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer[C]. Proc Am Soc Clin Oncol, 2011, 29Suppl: abstr LBA1003. [17] Nilsson G, Holmberg L, Garmo H. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke[J]. Br J Cancer, 2009, 100(5):811816. [18] Darby SC, McGale P, Taylor CW, et al. Longterm mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries[J]. Lancet Oncol, 2005, 6(8):557565. [19] MacDonald SM, Jimenez R, Paetzold P, et al. Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery[J]. Radiat Oncol, 2013, 8:71. [20] Qiu PF, Zhao RR, Liu YB, et al. Internal mammary sentinel lymph node biopsy should still be performed, especially in the patient with clinically positive axillary lymph nodes[J]. Breast, 2013, 22(5):9991000. [21] Dogan MH, Zincircioglu SB, Aydinol M. Research on different techniques in breast cancer radiotherapy[J]. Contemp Onco (Pozn), 2013, 17(3):291297. [22] Oh JL, Buchholz TA. Internal mammary node radiation: a proposed technique to spare cardiac toxicity[J]. J Clin Oncol, 2009, 27(31): e172173. |
[1] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[2] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[3] | 萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234. |
[4] | 杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238. |
[5] | 李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵.寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174. |
[6] | 李济时, 陆钊群, 刘俊茹, 吕建勋, 陈霜, 沈琳, 徐志渊, 吴平安.新辅助放疗联合部分喉切除术治疗喉滑膜肉瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(2): 123-125. |
[7] | 陈波光, 王苏贵, 张永杰.血清胆碱酯酶与炎症标志物在ⅠA~ⅢA期乳腺癌预后中的作用[J]. 国际肿瘤学杂志, 2024, 51(2): 73-82. |
[8] | 中国医师协会放射肿瘤治疗医师分会, 中华医学会放射肿瘤治疗学分会, 中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南(2023年版)[J]. 国际肿瘤学杂志, 2024, 51(1): 1-20. |
[9] | 高新雨, 李振江, 孙洪福, 韩丹, 赵倩, 刘成新, 黄伟.基于MR加速器的MR引导放疗在食管癌患者中的临床应用[J]. 国际肿瘤学杂志, 2024, 51(1): 37-42. |
[10] | 顾花艳, 朱腾, 郭贵龙.乳房微生物群与乳腺癌:现状与未来[J]. 国际肿瘤学杂志, 2024, 51(1): 55-58. |
[11] | 王景, 许文婷.中性粒细胞与淋巴细胞比值、癌胚抗原联合凝血指标对直径≤1.0 cm的良恶性乳腺结节鉴别诊断价值研究[J]. 国际肿瘤学杂志, 2023, 50(9): 520-526. |
[12] | 冯诚天, 黄芙蓉, 曹世玉, 王健宇, 南丁阿比雅思, 姜永冬, 朱娟英.HER2阳性乳腺癌患者HER2表达水平与影像学特征的关系[J]. 国际肿瘤学杂志, 2023, 50(9): 527-531. |
[13] | 崔腾璐, 吕璐, 孙鹏飞.放疗联合免疫治疗在头颈部鳞状细胞癌治疗中的应用[J]. 国际肿瘤学杂志, 2023, 50(9): 548-552. |
[14] | 冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456. |
[15] | 王文德, 曾德.乳腺癌内分泌治疗耐药的机制研究进展[J]. 国际肿瘤学杂志, 2023, 50(6): 352-356. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||